Zealand Pharma Announces FDA Approval of Zegalogue (dasiglucagon)
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…
March 24, 2021